Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19.
Med Mycol Case Rep
; 31: 29-31, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-957312
ABSTRACT
Severely ill influenza patients are at increased risk of invasive pulmonary aspergillosis (IPA). Previous reports suggest that Coronavirus Disease 2019 (COVID-19) patients may also be at increased risk of IPA. Here we present an Aspergillus co-infection in a COVID-19 immunocompetent patient, complicated by bacteremia and persistent hyperthermia. We describe the challenges in diagnosing IPA in COVID-19 immunocompetent patients and how the patient responded to the treatment.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
Med Mycol Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
J.mmcr.2020.11.004
Similar
MEDLINE
...
LILACS
LIS